Position in ESPR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
23,500
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EntryPoint Capital, LLC holds $3,628,447 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
95,427 | $954,270 | |
| 2 | ZTS |
Zoetis Inc.
|
10,184 | $731,822 | |
| 3 | HLN |
Haleon plc
|
69,665 | $649,974 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
80,750 | $639,540 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
4,181 | $346,103 | |
| 6 | SIGA |
Siga Technologies Inc
|
60,349 | $219,670 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
10,390 | $87,068 |
All Filings in ESPR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 23,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | — | 23,500 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||